1. Olaf K , Jan V , Manfred D . Uroplakin III is a highly specific and moderately sensitive immunohistochemical marker for primary and metastatic urothelial carcinomas.[J]. American Journal of Clinical Pathology, 2000(5):683.
2. Parker D C , Folpe A L , Bell J , et al. Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytokeratin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas.[J]. American Journal of Surgical Pathology, 2003, 27(1):1-10.
3. Koga F , Kawakami S , Fujii Y , et al. Impaired p63 Expression Associates with Poor Prognosis and Uroplakin III Expression in Invasive Urothelial Carcinoma of the Bladder[J]. Clinical Cancer Research An Official Journal of the American Association for Cancer Research, 2003, 9(15):5501-7.